-
Study aim
-
Determining the effect of adding dexmedetomidine, dexamethasone, and sodium bicarbonate to ropivacaine in the ultrasound-guided supraclavicular block on the quality of the block in orthopedic surgery
-
Design
-
A clinical trial with the control group, parallel groups, three-way blind, randomized, phase 3 on 120 patients. Random Allocation software was used for randomization.
-
Settings and conduct
-
Patients are placed in a semi-sitting position (30 degrees), then the supraclavicular block is performed by an ultrasound guide and half of the drug is injected in the pocket corner and the other half in the middle of the brachial plexus. All injections are performed using a spinal needle No. 22 connected to the Extension tube.
The drug used for the block is prepared and coded by the project partner as follows and is provided to the executor. The codes are provided to the executor after sampling and statistical analysis.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Age 18 years and older
Weight (Lean body mass) between 50 to 90 kg
ASA 1 and 2 were Introduced for upper limb surgery (distal to the lower third of the arm)
Exclusion criteria:
Local infection at the site of the block
Existence of coagulation disorder or taking anticoagulants
Hypersensitivity to dexmedetomidine, dexamethasone, and ropivacaine
-
Intervention groups
-
In all patients, the supraclavicular block is performed under ultrasound guide by injection of 30 ml of ropivacaine 5 mg/ml by the performer. In the first to third groups, the following items are added in a volume of one ml, respectively: 30 micrograms of dexmedetomidine, 0.6 ml of 7.5% bicarbonate solution, 4 mg (1 ml) of dexamethasone
In the control group, 1 ml of normal saline is added to the drug.
-
Main outcome variables
-
Interval of drug injection to the onset of sensory and motor block, duration of sensory and motor block